An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancerNishat Manzar, Bushra Ateeq, Shannon Carskadon et al.|iScience|2024Cited by 10
An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancerNishat Manzar, Bushra Ateeq, Ayush Goel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0